Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
about
Drug interactions with angiotensin receptor blockers.Development of selective non-peptide angiotensin II type 2 receptor agonists.Efficient and improved synthesis of Telmisartan.Overview of chemical diversity.Angiotensin antagonists.How the antihypertensive losartan was discovered.Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.Safety and efficacy of fimasartan in patients with arterial hypertension (Safe-KanArb study): an open-label observational studyAT1-receptor antagonism in hypertension: what has been learned with irbesartan?Emerging drugs for diabetic nephropathy.Small-molecule AT2 receptor agonists.PPARgamma Agonists: Potential as Therapeutics for Neovascular RetinopathiesCarboxylic acid (bio)isosteres in drug design.Thermal analysis study of antihypertensive drugs telmisartan and cilazapril.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.α-Amino Acid-Isosteric α-Amino Tetrazoles.Synthesis and Evaluation of 5-(o-Tolyl)-1H-tetrazole Derivatives as Potent Anticonvulsant Agents.Transforming Suzuki-Miyaura cross-couplings of MIDA boronates into a green technology: no organic solvents.2-(1H-Tetra-zol-5-yl)benzonitrile.Methyl 4-{[6-(4-bromo-phen-yl)-3-oxo-2,3,4,5-tetra-hydro-pyridazin-4-yl]methyl}benzoate.LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substratesDesign, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonistsLosartan: a selective angiotensin II type 1 (AT1) receptor antagonist for the treatment of heart failure.Pd-catalyzed coupling reaction of fluorinated propargyl amidines with aryl iodides.Role of the third intracellular loop of the angiotensin II receptor subtype AT2 in ligand-receptor interaction.Simultaneous determination of telmisartan and amlodipine in human plasma by LC-MS/MS and its application in a human pharmacokinetic study.1-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-pyrrolidine-2-carboxamide: investigation of structural variations.2-(1H-Benzimidazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol, a benzimidazole derivative, inhibits T cell proliferation involving H+/K+-ATPase inhibition.
P2860
Q33211891-CCC133E9-46E9-42AC-89D0-812264FAD567Q33514251-FFFDCEA6-820E-47E9-AEF4-8E37ED258402Q33868130-FB8F2753-774B-4405-9DF6-1E12D0141F38Q34040031-8265044C-C1B5-4C0E-9158-D3D59747D338Q34147092-230628F7-54C2-47D2-A982-9EE0DB30570EQ34333622-6E4ADFD4-207C-4B7C-A954-21AE38FF0EAEQ34543485-42AA8DDE-6F82-4A54-88CB-D94641400927Q34647575-0D54DD3C-08E7-426A-B0F4-3812C03ED829Q35696457-4F75ECF4-8E52-41DD-8698-C6A4A0850CA9Q36302838-25F8EFD4-2658-4C3F-8A30-D634626B63B0Q36400573-5B242D5D-B9EC-4294-BFA2-59640375F983Q36676571-51EE9ECB-8886-4AB0-858A-6802C91A416EQ36808250-08163A5E-8F53-45A2-B210-5F782A396079Q37712502-138041A2-39C2-4D2C-9093-8651342949DEQ38217456-6EABF79A-B771-4EA5-9E66-74DF195DB502Q38678578-514FBE88-B341-4007-ADF8-4CD3BDF6CE15Q38729062-12CB42C3-6444-426B-B6B9-387FAF740CF0Q39576854-7D38202A-E18C-4A4A-98B2-36C09201684FQ41845877-0EC37A8F-B561-40A7-87D6-51B2670A39E6Q41966455-B51E7E3B-38E2-4B69-9901-C77AA0EF9B41Q42221833-1D31A4A8-2934-42AB-8D05-E2BD6A4953DCQ42574149-570EADB0-AE56-4887-873E-0FAAE9D988FFQ46578436-181C580F-0C3F-478E-83E8-07C42BA7101FQ46949940-5AB7288B-29B6-4856-B1BA-E426C83F7DA6Q48922731-0C964B50-F660-4788-A87E-77691B1A63AFQ49680339-1AD138CA-4E13-4476-AA54-9B6BCB05B161Q51766954-52A34488-8E5C-4276-8899-2EE779CC64A3Q53008503-5145E0F6-6BC4-4ACE-AA3C-F77969537EB6
P2860
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Nonpeptide angiotensin II rece ...... n in antihypertensive therapy.
@ast
Nonpeptide angiotensin II rece ...... n in antihypertensive therapy.
@en
Nonpeptide angiotensin II rece ...... n in antihypertensive therapy.
@nl
type
label
Nonpeptide angiotensin II rece ...... n in antihypertensive therapy.
@ast
Nonpeptide angiotensin II rece ...... n in antihypertensive therapy.
@en
Nonpeptide angiotensin II rece ...... n in antihypertensive therapy.
@nl
prefLabel
Nonpeptide angiotensin II rece ...... n in antihypertensive therapy.
@ast
Nonpeptide angiotensin II rece ...... n in antihypertensive therapy.
@en
Nonpeptide angiotensin II rece ...... n in antihypertensive therapy.
@nl
P2093
P356
P1476
Nonpeptide angiotensin II rece ...... n in antihypertensive therapy.
@en
P2093
Goldberg MR
Greenlee WJ
Prendergast K
Timmermans PB
P304
P356
10.1021/JM9504722
P407
P577
1996-02-01T00:00:00Z